The focus of our work is the study and investigation of pathogens which are medically relevant or can be used as models for researching infection mechanisms.
To the research topics
Around 700 employees in research, administration and infrastructure, and about 140 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research.
Our scientists pursue research to expand our knowledge of the fundamental mechanisms behind medically relevant infectious diseases.
To the open positions
World Class research demands concentrated and focused support. To be internationally successful, adequate financial resources and a supportive environment are both important. This applies also to the Helmholtz Centre for Infection Research (HZI).
The Friends of the Helmholtz-Centre for Infection Research made it their business to support important activities of the centre. This concerns among others the results of basic research that is developed further to medical application.
Find out more about the work of the Helmholtz Centre for Infection Research in our videos, audio podcasts and picture galleries.
Results 1 to 9 of total 18
Editor (deputy Spokesperson)
+49 531 6181-1403
As early as 150 years ago, doctors observed a positive influence of bacterial infections in cancer patients. Despite much progress has been made in the past decades, this therapeutic approach failed to achieve a breakthrough. It remained unclear how the bacteria act against the tumour and what role the immune system plays in this complex process. Researchers at the Helmholtz Centre for...
Almost every human is a carrier of herpes viruses. Usually, an inactive form of the virus is present in the body. Problems due to the virus usually arise only when the immune system of the host is compromised. Scientists of the Helmholtz Centre for Infection Research (HZI) in Braunschweig now aim to study the underlying mechanism more closely in collaboration with colleagues from four...
The Kaposi's sarcoma-associated herpes virus (KSHV) is a tumour virus that is involved in the formation of various types of cancer. In infected cells of the body, the viral DNA is largely present in latent form. This means that the virus does not actively proliferate, but is copied passively just once during each cell division. The latent viral DNA is not incorporated directly into the...
The award-winner of the 2015 Hansen Family Award has been named: the Board of Trustees of the Bayer Science & Education Foundation and the Scientific Committee for this award have presented Professor Emmanuelle Charpentier with the EUR 75,000 prize, one of Germany’s most prestigious scientific accolades. The award is in recognition for her groundbreaking discoveries in the field of...
Cancer therapy involving bacterial infections? This sounds risky when you first think about it and many dangerous pathogens are indeed not the agent of choice in the fight against cancer. Though they may cause solid tumours to go into remission, they are harmful to the patient as well. Other bacteria might be harmless for the patient, but are also ineffective against cancer....
Helmholtz Centre for Infection ResearchInhoffenstraße 738124 Braunschweig+49 531 firstname.lastname@example.org
Helmholtz Institute for Pharmaceutical Research SaarlandCampus, Geb. C2.3Universität des Saarlandes66123 Saarbrücken+49 681 email@example.com
TWINCOREZentrum für Experimentelle und Klinische InfektionsforschungFeodor-Lynen-Str. 730625 Hannover+49 511 firstname.lastname@example.org
Study Centre HannoverFeodor-Lynen-Straße 1530625 Hannover+49 511 5350 email@example.com